| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/0024-3205(93)90152-S |
| P698 | PubMed publication ID | 8093631 |
| P50 | author | Jin-Chung Chen | Q41843136 |
| P2093 | author name string | E R Smith | |
| R Cohen | |||
| J B Fishman | |||
| M Cahill | |||
| P433 | issue | 4 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | morphine | Q81225 |
| fentanyl | Q407541 | ||
| opioid | Q427523 | ||
| P304 | page(s) | 389-396 | |
| P577 | publication date | 1993-01-01 | |
| P1433 | published in | Life Sciences | Q5256275 |
| P1476 | title | The opioid receptor binding of dezocine, morphine, fentanyl, butorphanol and nalbuphine | |
| P478 | volume | 52 |
| Q47124247 | "Comparison of Nalbuphine Hydrochloride and Fentanyl as an Adjuvant to Bupivacaine for Spinal Anesthesia in Lower Abdominal Surgeries:" A Randomized, Double-blind Study |
| Q47253931 | A Comparative Study of Analgesic Effect of Intrathecal Nalbuphine and Fentanyl as Adjuvant in Lower Limb Orthopaedic Surgery |
| Q38837328 | A multicenter randomized double-blind prospective study of the postoperative patient controlled intravenous analgesia effects of dezocine in elderly patients |
| Q44350347 | Activation of peripheral opioid µ-receptors in blood vessel may lower blood pressure in spontaneously hypertensive rats |
| Q35865452 | Acute morphine affects the rat circadian clock via rhythms of phosphorylated ERK1/2 and GSK3β kinases and Per1 expression in the rat suprachiasmatic nucleus |
| Q39172904 | Analgesic and Sedative Effects of Dezocine and Midazolam During Vitrectomy |
| Q56113559 | Analgesics and Antipyretics |
| Q35194392 | Anticipating and treating opioid-associated adverse effects |
| Q44352909 | Antinociceptive properties of FR140423 mediated through spinal delta-, but not mu- and kappa-, opioid receptors |
| Q92921262 | Assessing the Structural and Pharmacological Similarity of Newly Identified Drugs of Abuse to Controlled Substances Using Public Health Assessment via Structural Evaluation |
| Q80206540 | Beta-phenylethylamines and the isoquinoline alkaloids |
| Q43962629 | Blockade of the antinociceptive effect of spinally administered kyotorphin by naltrindole in mice |
| Q51547546 | Caudal epidural butorphanol plus bupivacaine versus bupivacaine in pediatric outpatient genitourinary procedures. |
| Q44343328 | Combination of low-dose nalbuphine and morphine in patient-controlled analgesia decreases incidence of opioid-related side effects |
| Q51409916 | Continuous epidural butorphanol relieves pruritus associated with epidural morphine infusions in children. |
| Q71018368 | Continuous epidural morphine/butorphanol infusion following selective dorsal rhizotomy in children |
| Q37661067 | Dezocine exhibits antihypersensitivity activities in neuropathy through spinal μ-opioid receptor activation and norepinephrine reuptake inhibition |
| Q60595378 | Effects of chronic fentanyl administration on behavioral characteristics of mice |
| Q52603584 | Efficacy of Nalbuphine with Flurbiprofen on Multimodal Analgesia with Transverse Abdominis Plane Block in Elderly Patients Undergoing Open Gastrointestinal Surgery: A Randomized, Controlled, Double-Blinded Trial. |
| Q90351974 | Fentanyl: Receptor pharmacology, abuse potential, and implications for treatment |
| Q21133651 | Genome-scale screening of drug-target associations relevant to Ki using a chemogenomics approach |
| Q90633762 | GluN2A-selective positive allosteric modulator-nalmefene-flumazenil reverses ketamine-fentanyl-dexmedetomidine-induced anesthesia and analgesia in rats |
| Q38851136 | In Vitro and In Vivo Metabolite Identification Studies for the New Synthetic Opioids Acetylfentanyl, Acrylfentanyl, Furanylfentanyl, and 4-Fluoro-Isobutyrylfentanyl. |
| Q42596062 | Interactions between opioids and cocaine on locomotor activity in rats: influence of an opioid's relative efficacy at the mu receptor. |
| Q42761352 | Intranasal Fentanyl Intoxication Leading to Diffuse Alveolar Hemorrhage |
| Q28477403 | Ligand-directed functional selectivity at the mu opioid receptor revealed by label-free integrative pharmacology on-target |
| Q43706636 | Modulation of breathing by mu1 and mu2 opioid receptor stimulation in neonatal and adult rats |
| Q38174596 | Morphine as a Potential Oxidative Stress-Causing Agent. |
| Q24194755 | Nalbuphine for postoperative pain treatment in children |
| Q24204019 | Nalbuphine for postoperative pain treatment in children |
| Q42380034 | Neurochemical Markers in the Mammalian Brain: Structure, Roles in Synaptic Communication, and Pharmacological Relevance |
| Q28658148 | Novel molecular targets of dezocine and their clinical implications |
| Q24604573 | Opiate-induced constipation related to activation of small intestine opioid μ2-receptors |
| Q34398867 | Opioid antagonist effects of dezocine in opioid-dependent humans. |
| Q44338259 | Opioid receptors and myocardial protection: do opioid agonists possess cardioprotective effects? |
| Q36807974 | Opioids and clonidine modulate cytokine production and opioid receptor expression in neonatal immune cells |
| Q91598924 | Pharmacological Characterization of Dezocine, a Potent Analgesic Acting as a κ Partial Agonist and μ Partial Agonist |
| Q57179360 | Placebo and Active Treatment Additivity in Placebo Analgesia: Research to Date and Future Directions |
| Q48149163 | Population pharmacokinetics of transdermal fentanyl in patients with cancer-related pain |
| Q55155287 | Predicting opioid receptor binding affinity of pharmacologically unclassified designer substances using molecular docking. |
| Q36230550 | Prostatic relaxation induced by loperamide is mediated through activation of opioid μ-2 receptors in vitro |
| Q58915143 | Prostatic relaxation induced by loperamide is reduced in spontaneously hypertensive rats |
| Q44348307 | Repeated restraint stress reduces opioid receptor binding in different rat CNS structures |
| Q45272304 | Rhodiola-water extract induces β-endorphin secretion to lower blood pressure in spontaneously hypertensive rats |
| Q43647880 | Sex differences in opioid antinociception: kappa and 'mixed action' agonists |
| Q28208172 | Sigma receptors: from discovery to highlights of their implications in the cardiovascular system |
| Q49803862 | Structural Insights into σ₁ Receptor Interactions with Opioid Ligands by Molecular Dynamics Simulations. |
| Q89912951 | Structure elucidation of urinary metabolites of fentanyl and five fentanyl analogues using LC-QTOF-MS, hepatocyte incubations and synthesized reference standards |
| Q48706431 | Subarachnoid butorphanol augments lidocaine sensory anaesthesia in calves |
| Q91234965 | The rising crisis of illicit fentanyl use, overdose, and potential therapeutic strategies |
| Q39343633 | Three-cycle fentanyl patch system significantly improves pain control in gynecologic cancer |
| Q39473943 | Transnasal butorphanol. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in acute pain management |
| Q34158082 | Uniform assessment and ranking of opioid μ receptor binding constants for selected opioid drugs |
| Q37455456 | kappa-Opioid receptor signaling and brain reward function |
Search more.